ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma
- PMID: 23481570
- DOI: 10.3233/CBM-130299
ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma
Abstract
Background and objectives: The aim of this study was to examine the pattern of SNPs in ECRG1 and FGFR4 gene of oral squamous cell carcinoma, and to evaluate the association between SNPs and prognostic parameters.
Materials and methods: Total 24 cases of oral squamous cell carcinoma patients were enrolled in this study. We analyzed the pattern of SNPs in ECRG1 and FGFR4 gene using PCR and direct sequence. Also we evaluated the association between SNPs pattern and clinicopathologic parameters of oral squamous cell carcinoma.
Results: The allele type Arg/Arg in ECRG1 gene was found in 13 (54.2%) patients, Arg/Gln in 11 (45.8%) patients and Gln/Gln in no patient. No clinical or pathological factor was associated with the SNP pattern in ECRG1. The allele types of FGFR4 amino acid 388 in 24 OSCC patients were Arg/Arg (8.3%), Arg/Gly (54.2%) and Gly/Gly (37.5%). No clinical or pathological factor was significantly associated with the SNP pattern except the nodal stage. The patients carrying FGFR4 allele Arg/Arg or Arg/Gly at amino acid 388 were associated with advanced N stage (pathologic N2+N3), compared to Gly/Gly allele carrying group (p=0.009).
Conclusion: This study is the first to describe a SNP pattern of both FGFR4 and ECRG1 gene with OSCC in Asian patients. In this study, FGFR4 Arg allele carrier was associated with higher N stage compared with Gly allele. If the important biological role of FGFR4 and ECRG1 in OSCC can be confirmed in further studies, this might be a rational to consider the evaluation of these genes as a therapeutic target in OSCC.
Similar articles
-
Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.Int J Oral Maxillofac Surg. 2009 Jul;38(7):779-84. doi: 10.1016/j.ijom.2009.02.021. Epub 2009 Apr 25. Int J Oral Maxillofac Surg. 2009. PMID: 19394797
-
The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.Exp Mol Pathol. 2007 Feb;82(1):53-7. doi: 10.1016/j.yexmp.2006.05.003. Epub 2006 Nov 3. Exp Mol Pathol. 2007. PMID: 17084840
-
FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.Oncol Rep. 2010 Mar;23(3):739-44. Oncol Rep. 2010. PMID: 20127014
-
FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.Eur J Cancer. 2010 Dec;46(18):3332-8. doi: 10.1016/j.ejca.2010.06.017. Epub 2010 Jul 16. Eur J Cancer. 2010. PMID: 20638838 Review.
-
ECRG1 and its relationship with esophageal cancer: a brief review.Onkologie. 2013;36(4):213-6. doi: 10.1159/000349960. Epub 2013 Mar 18. Onkologie. 2013. PMID: 23548972 Review.
Cited by
-
Roles of FGFR in oral carcinogenesis.Cell Prolif. 2016 Jun;49(3):261-9. doi: 10.1111/cpr.12260. Cell Prolif. 2016. PMID: 27218663 Free PMC article. Review.
-
Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.Oncotarget. 2017 Oct 23;8(56):96225-96238. doi: 10.18632/oncotarget.21958. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221201 Free PMC article.
-
Application of the Interaction between Tissue Immunohistochemistry Staining and Clinicopathological Factors for Evaluating the Risk of Oral Cancer Progression by Hierarchical Clustering Analysis: A Case-Control Study in a Taiwanese Population.Diagnostics (Basel). 2021 May 21;11(6):925. doi: 10.3390/diagnostics11060925. Diagnostics (Basel). 2021. PMID: 34063938 Free PMC article.
-
FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis.Front Oncol. 2021 Oct 19;11:762528. doi: 10.3389/fonc.2021.762528. eCollection 2021. Front Oncol. 2021. PMID: 34737965 Free PMC article.
-
Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.Target Oncol. 2016 Feb;11(1):17-27. doi: 10.1007/s11523-015-0374-9. Target Oncol. 2016. PMID: 26115874 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous